Literature DB >> 10541822

Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

K Ohtsuki1, K Akashi, Y Aoka, F G Blankenberg, S Kopiwoda, J F Tait, H W Strauss.   

Abstract

Either inadequate or excessive apoptosis (programmed cell death) is associated with many diseases. A method to image apoptosis in vivo, rather than requiring histologic evaluation of tissue, could assist with therapeutic decision making in these disorders. Programmed cell death is associated with a well-choreographed series of events resulting in the cessation of normal cell function, and the ultimate disappearance of the cell. One component of apoptosis is signaling adjacent cells that this cell is committing suicide by externalizing phosphatidylserine to the outer leaflet of the cell membrane. Annexin V, a 32-kDa endogenous human protein, has a high affinity for membrane-bound phosphatidylserine. We have coupled annexin V with the bifunctional hydrazinonicotinamide reagent (HYNIC) to prepare technetium-99m HYNIC-annexin V and demonstrated localization of radioactivity in tissues undergoing apoptosis in vivo. In this report we describe the results of a series of experiments in mice and rats to characterize the biologic behavior of (99m)Tc-HYNIC- annexin V. Biodistribution studies were performed in groups of rats at 10-180 min after intravenous injection of (99m)Tc-HYNIC-annexin V. In order to estimate the degree of apoptosis required for localization of (99m)Tc-annexin V in vivo, mice were treated with dexamethasone at doses ranging from 1 to 20 mg/kg, 5 h prior to (99m)Tc-HYNIC-annexin V administration, to induce thymic apoptosis. Thymus was excised 1 h after radiolabeled HYNIC-annexin V injection; thymocytes were isolated, incubated with Hoechst 33342 followed by propidium iodide, and analyzed on a fluorescence-activated cell sorter. Each sorted cell population was counted in a scintillation counter. To test (99m)Tc-HYNIC-annexin V as a tracer for external radionuclide imaging of apoptotic cell death, radionuclide imaging of Fas-defective mice (lpr/lpr mice) and wild-type mice treated with the antibody to Fas (anti-Fas) was carried out 1 h post injection. Rat biodistribution studies demonstrated a blood clearance half-time of less than 10 min for (99m)Tc-HYNIC-annexin V. The kidneys had the highest concentration of radioactivity at all time points. Studies in the mouse thymus demonstrated a 40-fold increase in (99m)Tc-HYNIC-annexin V concentration in apoptotic thymocytes compared with the viable cell population. A correlation of r=0.78 was found between radioactivity and flow cytometric and histologic evidence of apoptosis. Imaging studies in the lpr/lpr and wild-type mice showed a substantial increase of activity in the liver of wild-type mice treated with anti-Fas, while there was no significant change, irrespective of anti-Fas administration, in lpr/lpr mice. Excellent images of hepatic apoptosis were obtained in wild-type mice 30 min after injection of (99m)Tc-HYNIC-annexin V. The imaging results were consistent with histologic analysis in these animals. In conlusion, these studies confirm the value of (99m)Tc-HYNIC-annexin V uptake as a marker for the detection and quantification of apoptotic cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541822     DOI: 10.1007/s002590050580

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  24 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

Review 2.  What nuclear cardiology can learn from nuclear oncology.

Authors:  Ismet Sarikaya; Steven M Larson; Alvin Freiman; H William Strauss
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

Review 3.  Nuclear imaging of molecular processes in cancer.

Authors:  Rafael Torres Martin de Rosales; Erik Arstad; Philip J Blower
Journal:  Target Oncol       Date:  2009-09-25       Impact factor: 4.493

4.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 5.  Vulnerable plaque: definition, detection, treatment, and future implications.

Authors:  Kerem Ozer; Mehmet Cilingiroglu
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

Review 6.  In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure.

Authors:  F Blankenberg; J Narula; H W Strauss
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

7.  Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.

Authors:  Shuo Hu; Dale O Kiesewetter; Lei Zhu; Ning Guo; Haokao Gao; Gang Liu; Naoki Hida; Lixin Lang; Gang Niu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

8.  Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.

Authors:  Eyk A Schellenberger; Alexei Bogdanov; Alexander Petrovsky; Vasilis Ntziachristos; Ralph Weissleder; Lee Josephson
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

9.  ⁹⁹mTc-N4amG: synthesis biodistribution and imaging in breast tumor-bearing rodents.

Authors:  Ning Tsao; Mithu Chanda; Dong-Fang Yu; Hiroaki Kurihara; Yin-Han Zhang; Richard Mendez; David J Yang
Journal:  Appl Radiat Isot       Date:  2012-10-11       Impact factor: 1.513

10.  Myocardial uptake of 99mTc-annexin-V and 111In-antimyosin-antibodies after ischemia-reperfusion in rats.

Authors:  Laure Sarda-Mantel; Florence Hervatin; Jean-Baptiste Michel; Liliane Louedec; Geneviève Martet; François Rouzet; Rachida Lebtahi; Pascal Merlet; Ban-An Khaw; Dominique Le Guludec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.